Immuno-oncology Models
Immuno-oncology Translational Human Preclinical Models
Cellomatics Biosciences offers several well-validated immuno-oncology translational human preclinical models.
Immuno-oncology represents a specific targeted therapy by using the body’s immune system to destroy cancer cells. This does not involve surgery or use of radiation or chemotherapy and so it is fairly safe to the healthy cells of the body. It can be applicable at all stages of the disease, with higher efficiency.
Our immuno-oncology translational human preclinical models:
Request a consultation with Cellomatics Biosciences today
Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.
To request a consultation where we can discuss your exact requirements, please contact Cellomatics Biosciences.
